buspirone has been researched along with Cerebral Infarction, Middle Cerebral Artery in 1 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamei, K | 1 |
| Maeda, N | 1 |
| Katsuragi-Ogino, R | 1 |
| Koyama, M | 1 |
| Nakajima, M | 1 |
| Tatsuoka, T | 1 |
| Ohno, T | 1 |
| Inoue, T | 1 |
1 other study available for buspirone and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
New piperidinyl- and 1,2,3,6-tetrahydropyridinyl-pyrimidine derivatives as selective 5-HT1A receptor agonists with highly potent anti-ischemic effects.
Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Arterial Occlusive Diseases; Brain Ischemia; Cerebrov | 2005 |